Evelo Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Evelo Biosciences

29/07/2021 15:10

* Evelo Biosciences Inc  EVLO.OQ  reported a quarterly adjusted
loss of 53 cents​​ per share for the quarter ended in June. The
mean expectation of seven analysts for the quarter was for a
loss of 54 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Evelo Biosciences Inc's reported EPS for the quarter was a
loss of 59 cents​.
* The mean earnings estimate of analysts had risen by about 0.4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Evelo Biosciences Inc shares had fallen by 32.4% this
quarter and lost 23.2% so far this year.
* The company reported a quarterly loss of $31.6 million.
* Wall Street's median 12-month price target for Evelo
Biosciences Inc is $21.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated July 29 at 02:09 p.m.  ​All
figures in US dollars unless otherwise stated